高级检索
当前位置: 首页 > 详情页

Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT for tumor staging and primary tumor volume delineation in patients with nasopharyngeal carcinoma

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, Sichuan, People’s Republic of China. [3]Institute of Nuclear Medicine, Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China. [4]Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, No 25. Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China. [5]Department of Oncology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China.
出处:

关键词: 18F-FDG 68Ga-DOTATATE Nasopharyngeal cancer PET/CT

摘要:
This study evaluated the clinical utility of 68Ga-DOTATATE PET/CT compared to 18F-FDG PET/CT for tumor staging and the delineation of primary tumor volume in patients with non-keratinizing nasopharyngeal carcinoma (NPC). Forty-two individuals with pathologically confirmed non-keratinizing NPC were recruited. This study compared the detection rates of primary and metastatic tumors and the accuracy of tumor staging using two PET/CT modalities. Tumor volumes defined on PET scans using the absolute SUV of 2.5 (TH2.5), 40% of the maximum SUV (TH40%), and the relative background-dependent threshold (THbgd) were analyzed in comparison to MRI results. Comparing 68Ga-DOTATATE and 18F-FDG PET/CT, identifying primary tumors (initial detection, 100% vs. 97.3%; recurrent detection, 80.0% vs. 100%) and lymph node metastases (99.0% vs. 100%) were comparable. However, 68Ga-DOTATATE PET/CT detected more skull base bone (100% vs. 96.3%) and intracranial invasion (100% vs. 54.5%) than 18F-FDG, and consequently correctly upwardly adjusted the T-staging in 7 patients. 68Ga-DOTATATE PET/CT detected an equal number of lung metastases (24/24) but more bone metastases (97.8% vs. 84.4%) compared to 18F-FDG PET/CT, yet was less effective for liver metastases (30.4% vs. 100%). Compared with 18F-FDG PET/CT, 68Ga-DOTATATE PET/CT correctly upstaged 5 subjects and downstaged 1 subject in overall staging. Tumor volumes assessed by 68Ga-DOTATATE PET compared to 18F-FDG PET using the three threshold methods demonstrated less variability and higher agreement with MRI. Among the methods, THbgd for lesion segmentation in 68Ga-DOTATATE PET demonstrated the highest confidence level and concordance with MRI (ICC 0.95). In conclusion, 68Ga-DOTATATE PET/CT is a beneficial complement to 18F-FDG PET/CT for NPC staging, with higher accuracy for primary tumor volume delineation.© 2025. The Author(s).

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
最新[2025]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
第一作者:
第一作者机构: [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, Sichuan, People’s Republic of China. [3]Institute of Nuclear Medicine, Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, Sichuan, People’s Republic of China. [3]Institute of Nuclear Medicine, Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou 646000, Sichuan, People’s Republic of China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:59688 今日访问量:0 总访问量:4873 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号